How Does BetterLife Pharma Potentially Improve Existing Psychedelic Therapies?

BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF) (FRA: NPAU) CEO Dr. Ahmand Doroudian, PhD talks about the ways in which the company's second generation psychedelic drug candidates improve on the original versions.